Pancreatic Cancer: Planning Ahead for Metastatic Spread

Ingunn M. Stromnes, Philip D. Greenberg

Research output: Contribution to journalShort surveypeer-review

9 Scopus citations

Abstract

Metastasis and therapy resistance are cardinal features of pancreatic ductal adenocarcinoma, a commonly lethal malignancy. In this issue of Cancer Cell, Steele et al. show that CXCR2 expression and neutrophils are required for metastasis. In mice treated with advanced disease, inhibiting both CXCR2 and PD1 cooperatively but not individually prolongs survival.

Original languageEnglish (US)
Pages (from-to)774-776
Number of pages3
JournalCancer Cell
Volume29
Issue number6
DOIs
StatePublished - Jun 13 2016

Bibliographical note

Publisher Copyright:
© 2016

Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'Pancreatic Cancer: Planning Ahead for Metastatic Spread'. Together they form a unique fingerprint.

Cite this